🔆 📖 👤

Statutory Instruments

2009 No. 2820

Medicines

The Medicines for Human Use (Marketing Authorisations Etc.) Amendment Regulations 2009

Made

19th October 2009

Laid before Parliament

26th October 2009

Coming into force

1st January 2010

The Secretary of State makes these Regulations in exercise of the powers conferred by section 2(2) of the European Communities Act 1972( 1 ). He has been designated for the purposes of that section in relation to medicinal products( 2 ).

Citation, commencement and interpretation

1. —(1) These Regulations may be cited as the Medicines for Human Use (Marketing Authorisations Etc.) Amendment Regulations 2009 and shall come into force on 1st January 2010.

(2) In these Regulations, the “1994 Regulations” means the Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994( 3 ).

Amendment of paragraph 7 of Schedule 2 to the 1994 Regulations

2. For paragraph 7 of Schedule 2 to the 1994 Regulations (requirement to consult the appropriate committee) substitute the following paragraph—

7. —(1) The licensing authority shall not, at any time while this Schedule applies—

(a) unless the circumstances described in sub-paragraph (2) apply, refuse to grant or renew the authorization applied for; or

(b) revoke, vary or (subject to paragraph 12 of this Schedule) suspend an authorization,

on grounds relating to safety, quality or efficacy, except after consultation with the appropriate committee.

(2) The circumstances for the purposes of sub-paragraph (1)(a) are—

(a) the licensing authority has requested the applicant to supply information which the licensing authority regards as relevant to enable the application to be determined; and

(b) the information has not been supplied to the licensing authority within the relevant period.

(3) In sub-paragraph (2) the “relevant period” is—

(a) where the licensing authority has completed its initial full assessment of the application, the period of six months beginning with the date on which the licensing authority requested the applicant to supply the information referred to in sub-paragraph (2)(a); or

(b) where the licensing authority has completed its assessment of any supplemental information, the period of three months beginning with the date on which the licensing authority requested the applicant to supply the information referred to in sub-paragraph (2)(a).

(4) The applicant may at any time before the relevant period has expired submit a request to the licensing authority for the period to be extended.

(5) An applicant requesting an extension of the relevant period must provide grounds on which the request is made.

(6) Where an applicant has submitted a request in accordance with sub-paragraphs (4) and (5), the licensing authority may extend the relevant period in accordance with the request provided it considers that the grounds on which it is made are exceptional. .

Signed by authority of the Secretary of State for Health

Mike O’Brien

Minister of State

Department of Health

19th October 2009

( 1 )

1972 c.68 ; section 2(2) was amended by the Legislative and Regulatory Reform Act 2006 (c.51) , section 27(1)(a).

( 3 )

S.I. 1994/3144 ; the relevant amending instrument is S.I. 2005/1094 .

Status: This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
The Medicines for Human Use (Marketing Authorisations Etc.) Amendment Regulations 2009 (2009/2820)

Displaying information

Status of this instrument

footnotecommentarytransitional and savingsin force statusrelated provisionsgeo extentinsert/omitsource countin force adj
Defined TermSection/ArticleIDScope of Application
1994 Regulationsreg. 1.1994_Regul_rtEEnXm

Status of changes to instrument text

The list includes made instruments, both those in force and those yet to come into force. Typically, instruments that are not yet in force (hence their changes are not incorporated into the text above) are indicated by description 'not yet' in the changes made column.